Skip to main navigation
Toggle Navigation
Search:
About Us
Our Company
Leadership
Board of Directors
Kadmon Commitment
Contact
Clinical Pipeline
About KD025
KD025 in Systemic Sclerosis
KD025 in cGVHD
Clinical Trials
Commercial Products
Science
Preclinical Pipeline
Biologics
Monoclonal Antibody Discovery Platform
IL-18 Platform
Small Molecules
Structure-Based Drug Design
Publications
Products
Investors
Investors Home
News & Events
Press Releases
Presentations and Events
Stock Information
Stock Quote & Chart
Analyst Coverage
Historic Price Lookup
Financials & Filings
Corporate Governance
Documents & Charters
Management
Board of Directors
Investor Resources
Investor/Media FAQs
Contact Us
Email Alerts
Search:
Contact
Investors
Contact Us
Contact Us
Contact Us
Name
Email
Subject
Comments
Print Page
Email Alerts
Contact Us
Investors Home
News & Events
Press Releases
Presentations and Events
Stock Information
Stock Quote & Chart
Analyst Coverage
Historic Price Lookup
Financials & Filings
Corporate Governance
Documents & Charters
Management
Board of Directors
Investor Resources
Investor/Media FAQs
Contact Us
Email Alerts
Investor Inquiries
Ellen Cavaleri
646.490.2989
investors@kadmon.com
Media Inquiries
1.833.900.5366
media@kadmon.com
